Uterine fibroids, medically termed leiomyomas or myomas, are benign monoclonal tumors originating from the smooth muscle cells of the myometrium. They are the most common pelvic tumors in females of reproductive age, though many individuals remain entirely asymptomatic throughout their lives. The size of these growths varies widely, ranging from microscopic nodules to bulky masses that can significantly distort the uterine cavity. Despite their non-cancerous nature, fibroids frequently lead to distressing clinical symptoms that impact daily life and reproductive health.
The exact trigger for myoma development remains a subject of ongoing study, but several well-established biological drivers exist:
Key risk factors include African descent, early menarche, nulliparity, family history, and obesity.
Anatomical location dictates both the symptoms a patient experiences and the surgical approach required for treatment. Clinicians categorize fibroids based on their position relative to the uterine walls:
While some women experience no discomfort, symptomatic patients often present with a recognizable pattern of complaints. Menstrual disturbances are classic, especially menorrhagia (heavy or prolonged bleeding) that can lead to iron deficiency anemia. Pressure symptoms also develop as enlarging masses crowd neighboring pelvic organs. Patients may report urinary frequency from bladder compression, constipation from rectal pressure, and chronic pelvic heaviness or dysmenorrhea.
Diagnosing uterine fibroids begins with a thorough clinical history and a bimanual pelvic examination, which often reveals an enlarged, irregular, or firm uterus. Pelvic ultrasound is the primary imaging modality used to confirm the diagnosis, determine fibroid size, and map anatomical locations. Magnetic resonance imaging provides more detailed mapping when surgical planning is complex. Nurses play a crucial role during assessments by evaluating pain levels, quantifying menstrual blood loss through pad counts, and checking complete blood count results for signs of anemia.
Treatment strategies range from conservative medical therapy to definitive surgical intervention, depending on the severity of symptoms, age, and fertility desires.
Medical options aim to control bleeding and shrink masses. Gonadotropin-releasing hormone agonists induce a temporary menopausal state, while hormonal contraceptives regulate cycles.
Surgical choices include myomectomy, which removes only the fibroids and preserves the uterus for future pregnancies, and hysterectomy, which involves complete removal of the uterus and serves as the definitive cure.
While many fibroids cause minor inconvenience, certain presentations lead to significant complications. Submucosal and large intramural myomas can distort the uterine architecture, impairing embryo implantation and resulting in recurrent pregnancy loss or infertility. During pregnancy, fibroids may undergo red degeneration due to outgrowing their blood supply, causing acute localized pain. They also increase the risk of malpresentation, preterm labor, and postpartum hemorrhage due to poor uterine contractility.
Comprehensive nursing care for patients with uterine fibroids extends beyond physical treatment to address emotional well-being and lifestyle support. Nurses provide education regarding treatment options, surgical preparation, and potential recovery expectations. Pain management support involves administering prescribed analgesics and teaching non-pharmacological comfort measures. Addressing psychological distress is equally important, as chronic heavy bleeding and fertility concerns often take a heavy emotional toll on the patient.